Gynaecological surgery is of high emetogenic potential and both total intravenous anaesthesia (TIVA) and prophylactic antiemetic therapy may reduce the incidence of postoperative nausea and vomiting (PONV).
Between 50% and 70% of all surgery is now performed on a day-case basis and postoperative nausea and vomiting (PONV) is experienced by 30 to 50% of patients, irrespective of prophylactic antiemetic administration 1, 2 . Females undergoing gynaecological laparoscopic surgery have among the highest rates of PONV 1 . Although often overlooked previously, persisting PONV after discharge home may be common 3 .
The cost implications of severe PONV on ambu-latory health-care are enormous 4, 5 . Uncontrolled PONV remains the most important determinant of length of stay and the leading cause of unplanned admission to hospital 6, 7 . Post-discharge PONV causes a substantial indirect cost in terms of loss of productivity for both patients and those caring for them 8 . From the patient's perspective, severe PONV is one of the leading causes of dissatisfaction with anaesthesia 9 , and a high value is placed on its avoidance 10 .
Anaesthetic techniques that minimize side-effects and allow early discharge are essential for day-case anaesthesia. Propofol is the favoured induction drug because of its rapid recovery characteristics, acceptable side-effect profile and good patient acceptance. Antiemetic prophylaxis with dolasetron or with droperidol is cost-effective and associated with increased patient satisfaction in this population 11,12 . However, despite propofol induction and prophylactic antiemetic administration, up to 50% of women remain nauseous and many require rescue antiemetic therapy 3 .
Total intravenous anaesthesia (TIVA) has been associated with earlier recovery and reduced PONV compared with balanced anaesthesia with inhalational agents for ambulatory gynaecological surgery [13] [14] [15] [16] [17] . The most recent meta-analysis of TIVA for all types of surgery identified a significantly reduced incidence of PONV in comparison with inhalational agents, regardless of induction or inhalational agent and use of nitrous oxide or opioid 18 . However, a previous meta-analysis concluded that there was insufficient evidence that TIVA reduced late PONV 19 .
It is not known whether the combination of TIVA with prophylactic antiemetic confers any further benefit. In one study both the TIVA and the inhalational anaesthesia groups received antiemetic 14 , but we are not aware of any randomized study comparing TIVA alone to TIVA with a prophylactic antiemetic in a high-risk ambulatory patient population.
This study was conducted to compare the incidence of nausea and vomiting using TIVA with or without dolasetron, with that of balanced inhalational anaesthesia using sevoflurane and dolasetron in the immediate and late postoperative period. The primary outcome was the complete response (absence of vomiting and antiemetic treatment) of patients undergoing day-case gynaecological laparoscopy.
METHODS
This prospective, randomized, blinded, controlled trial was approved by the Institutional Research and Ethics Committee. One hundred and forty-four unpremedicated patients scheduled for day-case gynaecological laparoscopy gave written informed consent and were enrolled in the study. Exclusion criteria included contraindications or allergies to any drugs used in the study; current symptoms of nausea or vomiting; treatment with drugs with antiemetic activity; and patient preference for premedication. If the operative procedure was changed such that inpatient admission was required on surgical grounds, the patient was withdrawn from the study.
Patient demographic data collected included age, weight and history of PONV, motion sickness and cigarette smoking. Patients were randomized according to a computer-generated random number sequence using a sealed envelope technique and were stratified according to the current phase of their menstrual cycle.
The general anaesthetic techniques for the groups were standardized. Prior to induction with a titrated dose of intravenous (IV) propofol, all patients received IV midazolam 2 mg and alfentanil 250 µg. Ventilation was controlled, via either an oral tracheal tube or a laryngeal mask airway, using a nondepolarizing relaxant of the attending anaesthetist's choice. Intraoperative analgesia was provided with additional alfentanil and IV morphine 5 to 10 mg as required. For the calculation of opioid use perioperatively, alfentanil dose was converted to morphine equivalents using 100 µg alfentanil equivalent to 1 mg morphine.
Randomization was to one of three anaesthetic techniques. The inhalational group (group I+D) received prophylactic IV dolasetron 12.5 mg followed by propofol for induction, then sevoflurane and nitrous oxide in oxygen for maintenance. Both TIVA groups had propofol induction, then an intravenous propofol infusion commencing at 10 mg/kg/h. For all groups, clinical parameters were used to titrate maintenance anaesthetic agent to an adequate depth of anaesthesia. The TIVA groups either received (group T+D) or did not receive (group T) prophylactic IV dolasetron 12.5 mg at induction. Near the completion of surgery, the propofol infusion or sevoflurane was ceased and rectal diclofenac 100 mg administered. Neuromuscular blockade was reversed with neostigmine 2.5 mg and atropine 1.2 mg or glycopyrrolate 0.4 mg as required. Postoperative analgesia was provided with titrated IV morphine initially, followed by oral paracetamol 1g with codeine 30 mg or subsequently, intramuscular morphine if necessary. First line rescue antiemetic treatment was intramuscular prochlorperazine 12.5 mg, given for any vomiting episode or for nausea on demand. If this was ineffective after an hour, further second line rescue treatment was provided with IV droperidol 1 mg and third line with IV ondansetron 4 mg.
Patients were unaware of their group allocation, and postoperative nursing staff and research nurses collecting data were blind to the use of antiemetic, but the anaesthetic chart detailing anaesthetic drugs administered was not concealed. Assessments were commenced 15 minutes after arrival in the first stage recovery room and then hourly thereafter in the day surgical unit recovery area until discharge or a maximum of 6 hours postoperatively. Nausea was assessed using a visual analog scale (VAS) for both current and worst nausea, and using a subjective rating based on the patient's attitude toward emetic symptoms. Vomiting episodes, antiemetic treatment and unplanned overnight admission were recorded.
Prior to discharge from the day-care facility, patient satisfaction with control of PONV was evaluated using a VAS and times to ambulation, oral fluid intake and micturition recorded. Patients were interviewed by telephone 24 hours postoperatively and on the fourth postoperative day regarding post-discharge vomiting episodes, severity of nausea and treatment. Using a 0 to 10 verbal scale, satisfaction with the control of nausea and with recovery from the procedure was assessed. The time taken to resume normal activities at home, to return to work and for "feeling back to normal" was assessed.
The study sample size was based on a desire to detect a reduction in the incidence of vomiting or requirement for antiemetic from 60% with balanced inhalational anaesthesia to 30% with propofol TIVA, and a reduction from 30% to 10% in those having TIVA with dolasetron, with a corrected type 1 error rate of 5% and power of 80%. The primary outcome was the incidence of complete response, defined as the absence of both vomiting and treatment for either nausea or vomiting. Parametric variables were analysed using the F test and Student's t test. Categorical data were analysed using chi square tests. Non-parametric outcomes such as visual analog pain scores and morphine use were compared using Kruskal-Wallis tests. The effect of morphine, menses and use of LMA on the complete response was examined using logistic regression modelling. The time to first vomiting episode was analysed using Kaplan-Meier survival functions with log rank tests. A P value of <0.05 was considered statistically significant.
RESULTS
One hundred and thirty-nine women completed the study (group I+D n=47, group T+D n=45, group T n=47). Data was not available for five patients, four due to hospital admission following more complex surgery and one in whom it was not collected after a major protocol violation.
There were no significant differences among the groups with respect to patient demographics, perioperative management, the requirement for postoperative opioid analgesia or the intraoperative and total dose of morphine administered (Table 1) .
A "complete response" (no vomiting and no treatment for PONV required) prior to discharge was seen in 34% (group I+D), 51% (group T+D) and 32% (group T) (P=0.12). In contrast to total morphine dose (odds ratio for a complete response 0.95, CI 0.91-0.99, P=0.019), timing within the menstrual cycle and use of an LMA did not significantly affect complete response. Using logistic regression modelling, there was also no significant difference between groups after adjusting for morphine administered.
Group T had an earlier time to first vomiting compared with the other groups (Figure 1 ). The incidence of vomiting for each hourly period postoperatively is 155 ANAESTHETIC TECHNIQUE AND POSTOPERATIVE EMESIS Values are number (percentage) except age and weight, which are mean (SD), and duration of surgery, which is median (1st, 3rd quartiles). shown in Figure 2 . All groups had low nausea scores during hospital admission, however, group I+D had higher nausea scores in the first hour (P=0.02, Table 2 ). There was no significant difference among the groups for the number of patients who had not required rescue antiemetic treatment up to 6 hours postoperatively (Figure 3 ). At 4 hours postoperatively 29%, 26% and 23% in groups I+D, T+D and T respectively had received treatment (P=0.85). The number of patients receiving first, second and third line rescue antiemetic treatment did not differ significantly, with the number receiving third line being 7 (15%), 7 (16%) and 14 (30%) in groups I+D, T+D and T respectively (P=0.13). The median (1st, 3rd quartiles) number of times rescue treatment was administered also did not differ significantly (1 (0,2), 0 (0,2) and 1 (0,3) in groups I+D, T+D and T respectively (P=0.17).
There was no significant difference among groups for unplanned admission due to severe PONV (group I+D 5 (10.6%), group T+D 1 (2.2%) and group T 6 (12.8%), P=0.16). Groups were similar with respect to patient attitude toward PONV prior to discharge and for median (1st, 3rd quartiles) patient satisfaction scores for control of PONV (100 (70,100) , 100 (80,100) and 100 (88,100) groups I+D, T+D and T respectively, P=0.53). There were no significant differences among groups for times to first ambulation, first oral fluid intake or ability to micturate.
Groups were similar for post-discharge incidence of vomiting and antiemetic treatment. However, significantly more patients in group I+D experienced nausea (P<0.05), the severity of nausea was greater and satisfaction scores were lower (both P<0.05, Table 3 ). The number of days before normal activities could be resumed was a median of 3 in all groups. The number of women feeling fully recovered from their operation at 96 hours postoperatively was similar.
DISCUSSION
Despite the very high rate of PONV associated with day-case gynaecological laparoscopy 1,2 and evidence that TIVA reduces PONV 18 , balanced inhalational anaesthesia remains very popular. Although our omission of a group receiving inhalational anaesthetic without prophylactic dolasetron can be criticized, we did not consider it ethical to include a study arm using this approach. The prophylactic administration of either droperidol or a 5-hydroxytryptamine 3 (5-HT 3 ) antagonist is costeffective 11, 12 and this is routine clinical practice in our hospital.
Many studies have investigated PONV in ambulatory surgery following TIVA 18 and some anaesthetists would also administer a prophylactic antiemetic, although there are no controlled comparisons to supporting this approach. Although the complete response (no vomiting or rescue treatment for PONV during the period of hospital stay) did not differ between groups, our results suggested TIVA with prophylactic dolasetron conferred an advantage over the alternative approaches in both the inpatient and outpatient phase after gynaecological laparoscopy. Both early and post-discharge nausea was less common than after a balanced inhalational technique including dolasetron. Although failing to reach statistical significance, the propofol TIVA plus dolasetron group had the highest complete response rate, the least number of rescue treatment interventions and the lowest rate of unplanned admission.
The power of the study to detect a true difference in admission rate was only 23%, and a sample size of 123 patients per group would have been necessary to achieve significance if this was a real difference.
Propofol has direct antiemetic properties in subhypnotic doses 20 , probably due to a depressant effect on the chemoreceptor trigger zone, vagal nuclei and other subcortical structures rather than strong interaction with D 2 dopamine receptors 21 . The effective plasma concentrations for 50% reduction in nausea scores after surgery are about 200-600 ng/ml 22 .
A recommended single daily intravenous dose of 12.5 mg of dolasetron, a new 5-HT 3 antagonist, is more effective than placebo for the prevention of PONV after gynaecological laparoscopy 23 . It has a side-effect profile comparable to placebo 23 and is as cost-effective as droperidol in high-risk patients 11 . Although injection at cessation of anaesthesia may be more effective for other 5-HT 3 antagonists 24 , the duration of surgery in this study was short and when this trial commenced the optimal timing of administration of the 5-HT 3 antagonists was uncertain.
Eriksson and Kortilla found that a combination of balanced inhalational anaesthesia using desflurane and prophylactic ondansetron was comparable to propofol TIVA alone with respect to PONV 17 . In contrast, our study found that emergence nausea was more severe after inhalational anaesthetic. This is consistent with a small study by Collins et al 14 , in which nausea was more common in the first two postoperative hours after inhalational anaesthesia compared with TIVA, despite antiemetic prophylaxis in both groups. In addition, although dolasetron delayed the onset of vomiting, patients receiving inhalational anaesthesia were more likely to experience nausea following discharge from our day unit.
Although observers were unaware of the specific TIVA group allocation, it is possible the efficacy of TIVA was overestimated in this open study. While TIVA is used less commonly than balanced inhalational anaesthesia in our unit, those collecting inpatient data were aware of the potential advantage of TIVA with respect to PONV. Nevertheless, the postdischarge outcomes were patient-reported and unlikely to have been influenced.
The complete response rate in all groups in this study was lower than that reported by other investigators 17, 23, 25 . Rescue treatment was similar or higher than other studies using prophylactic antiemetics of various types or TIVA alone 2, 16 . These differences are probably methodological, in that despite a similar definition for "complete response", the studies varied in their definition of nausea and the threshold for rescue intervention varied. We considered nausea absent only when nausea scores were zero at all assessments, and instituted treatment after any episode of vomiting or patient complaint of nausea. In contrast, other investigators, who found a 50% or more complete response with balanced anaesthesia and dolasetron or with TIVA alone, did not commence treatment until 15 minutes of continuous nausea or after more than one or two emetic episodes 17, 23, 25 .
Some units claim exceptionally low rates of PONV (<10%) in the first six hours postoperatively after laparoscopy when the anaesthetic technique is TIVA with or without antiemetic prophylaxis, spontaneous ventilation through an LMA and avoidance of opioids 26 . Gastric insufflation is a potential complication of controlled ventilation through an LMA, however we found use of an LMA had no influence on the complete response rate. In addition, despite the use of nonsteroidal anti-inflammatory drugs, over 50% of our patients required postoperative opioid and perioperative morphine was the only factor significantly associated with nausea and vomiting. Further investigation, comparing spontaneous and controlled ventilation and strategies that reduce the need for postoperative opioids, would be of interest.
An unanticipated and important finding of this study related to patient outcome after discharge home, a period that has been neglected in most previous studies. It is now appreciated that postdischarge PONV is common, with an incidence of 30 to 50%, after balanced inhalational anaesthesia 3, 27 . Many such patients experience emetic symptoms for the first time after discharge from hospital 27 . In this study over 50% of those having inhalational anaesthetics felt nauseous and almost 40% vomited at least once following discharge. Recent studies have found no benefit for post-discharge PONV from the perioperative administration of a single dose of promethazine, cyclizine or ondansetron 2,3 . We observed less nausea and higher patient satisfaction in the patients receiving TIVA, and the propofol TIVA plus dolasetron group had the lowest incidence of post-discharge nausea.
In conclusion, we found that TIVA, with or without dolasetron, reduced nausea in the first hour after gynaecological laparoscopy and also after daysurgical discharge, when compared with balanced anaesthesia with sevoflurane plus dolasetron. In comparison with TIVA alone, the addition of a longacting 5-HT 3 antagonist delayed the onset of vomiting and reduced post-discharge nausea, but did not significantly reduce either vomiting or rescue antiemetic requirement. A larger study would be required to determine the cost-effectiveness of such prophylaxis and whether unplanned admission to hospital is reduced.
